Evidence map›Paper›PMID 20924973›Full record

ReviewNutrition and cancer2010

Chemopreventive potential of natural compounds in head and neck cancer.

Mohammad Aminur Rahman, A R M Ruhul Amin, Dong M Shin

Open access · greenAbstract readReview
In one paragraph

Review in Nutrition and cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Molecular pathways modulated by phytochemicals in head and neck cancer.Journal of cell communication and signaling · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Anti-Cancer Effect of 3-Hydroxy-β-Ionone Identified fromMolecules (Basel, Switzerland) · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.Cancer prevention research (Philadelphia, Pa.) · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammad Aminur RahmanDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.
A R M Ruhul Amin
Dong M Shin
Emory University · US

Funding

TARGETING DEATH RECEPTOR-MEDIATED APOPTOSIS FOR HEAD AND NECK CANCERP50CA128613 · NCI · EMORY UNIVERSITY · PI SHIN, DONG M · 2007 to 2011
$12.0M
Chemoprevention of the Head and Neck Cancer with ZD1839*U01CA101244 · NCI · EMORY UNIVERSITY · PI SHIN, DONG M · 2004 to 2008
$3.1M
Second Primary Tumor Prevention w/EGFR TKIs & COX-2 inhibitors in H & N CancerR01CA112643 · NCI · EMORY UNIVERSITY · PI SHIN, DONG M · 2006 to 2011
$1.6M
NCI NIH HHS P50 CA128613NCI NIH HHS R01 CA112643NCI NIH HHS U01 CA101244
6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is one of the most fatal cancers worldwide. Despite advances in the management of HNSCC, the overall survival for patients has not improved significantly due to advanced stages at diagnosis, high recurrence rate after surgical removal, and second primary tumor development, which underscore the importance of novel strategies for cancer prevention. Cancer chemoprevention, the use of natural or synthetic compounds to prevent, arrest, or reverse the process of carcinogenesis at its earliest stages, aims to reverse premalignancies and prevent second primary tumors. Genomics and proteomics information including initial mutation, cancer promotion, progression, and susceptibility has brought molecularly targeted therapies for drug development. The development of preventive approaches using specific natural or synthetic compounds, or both, requires a depth of understanding of the cross-talk between cancer signaling pathways and networks to retain or enhance chemopreventive activity while reducing known toxic effects. Many natural dietary compounds have been identified with multiple molecular targets, effective in the prevention and treatment of cancer. This review describes recent advances in the understanding of the complex signaling networks driving cancer progression and of molecularly targeted natural compounds under preclinical and clinical investigation.

Indexed as

AnimalsAnticarcinogenic AgentsCarcinoma, Squamous CellCatechinCurcuminCyclooxygenase 2 InhibitorsErbB ReceptorsHead and Neck NeoplasmsHumansNF-kappa BResveratrolStilbenesTOR Serine-Threonine KinasesTumor Suppressor Protein p53Anticarcinogenic AgentsCatechinCurcuminCyclooxygenase 2 Inhibitorsepigallocatechin gallateErbB ReceptorsNF-kappa BResveratrolStilbenesTOR Serine-Threonine KinasesTumor Suppressor Protein p53

Identifiers

PMID20924973
PMCPMC3744227
OpenAlexW2042912673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.